AD-1211 is an opioid analgesic drug invented in the 1970s by Dainippon Pharmaceutical Co. It is chemically a 1-substituted-4-prenyl-piperazine derivative, which is structurally unrelated to most other opioid drugs. The (S)-enantiomers in this series are more active as opioid agonists, but the less active (R)-enantiomer of this compound, AD-1211, is a mixed agonist–antagonist at opioid receptors with a similar pharmacological profile to pentazocine,[1] and has atypical opioid effects with little development of toleranceordependence seen after extended administration in animal studies.[2][3]
Clinical data | |
---|---|
Other names | AD-1211 |
ATC code |
|
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
ChemSpider |
|
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C23H30N2O |
Molar mass | 350.506 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
This analgesic-related article is a stub. You can help Wikipedia by expanding it. |